Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zoe Kopp

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Neurourology and Urodynamics|March 15, 2012
What are the best outcome measures when assessing treatments for LUTD?--achieving the most out of outcome evaluation: ICI-RS 2011N Cotterill, H Goldman, Con Kelleher, et al.
European Urology|June 25, 2010
Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic reviewDebra E Irwin, Ian Milsom, Michael B Chancellor, et al.
Archives of Internal Medicine|March 26, 2002
Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failureBarbara Riegel, Beverly Carlson, Zoe Kopp, et al.
Disease Management : DM|July 2, 2004
ME Cares: a statewide system engaging providers in disease managementRichard Wexler, Claudette Bean, Diane Ito, et al.
Neurourology and Urodynamics|June 15, 2007
Development and validation of the Overactive Bladder Satisfaction (OAB-S) QuestionnaireElisabeth Piault, Christopher J Evans, Derek Espindle, et al.
BJU International|March 13, 2009
The economic impact of overactive bladder syndrome in six Western countriesDebra E Irwin, Laura Mungapen, Ian Milsom, et al.
European Urology|March 13, 2009
Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladderDebra E Irwin, Ian Milsom, Zoe Kopp, et al.
European Urology|June 7, 2006
The current and future burden and cost of overactive bladder in five European countriesPenny Reeves, Deb Irwin, Con Kelleher, et al.
International Journal of Cardiology|July 10, 2002
A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and CanadaErik Thaulow, Bjorn Jorgensen, John J Doyle, et al.
Urology|March 11, 2006
Translating overactive bladder questionnaires in 14 languagesCatherine Acquadro, Zoe Kopp, Karin S Coyne, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Neurourology and Urodynamics|March 15, 2012
What are the best outcome measures when assessing treatments for LUTD?--achieving the most out of outcome evaluation: ICI-RS 2011N Cotterill, H Goldman, Con Kelleher, et al.
European Urology|June 25, 2010
Dynamic progression of overactive bladder and urinary incontinence symptoms: a systematic reviewDebra E Irwin, Ian Milsom, Michael B Chancellor, et al.
Archives of Internal Medicine|March 26, 2002
Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failureBarbara Riegel, Beverly Carlson, Zoe Kopp, et al.
Disease Management : DM|July 2, 2004
ME Cares: a statewide system engaging providers in disease managementRichard Wexler, Claudette Bean, Diane Ito, et al.
Neurourology and Urodynamics|June 15, 2007
Development and validation of the Overactive Bladder Satisfaction (OAB-S) QuestionnaireElisabeth Piault, Christopher J Evans, Derek Espindle, et al.
BJU International|March 13, 2009
The economic impact of overactive bladder syndrome in six Western countriesDebra E Irwin, Laura Mungapen, Ian Milsom, et al.
European Urology|March 13, 2009
Prevalence, severity, and symptom bother of lower urinary tract symptoms among men in the EPIC study: impact of overactive bladderDebra E Irwin, Ian Milsom, Zoe Kopp, et al.
European Urology|June 7, 2006
The current and future burden and cost of overactive bladder in five European countriesPenny Reeves, Deb Irwin, Con Kelleher, et al.
International Journal of Cardiology|July 10, 2002
A pharmacoeconomic evaluation of results from the Coronary Angioplasty Amlodipine Restenosis Study (CAPARES) in Norway and CanadaErik Thaulow, Bjorn Jorgensen, John J Doyle, et al.
Urology|March 11, 2006
Translating overactive bladder questionnaires in 14 languagesCatherine Acquadro, Zoe Kopp, Karin S Coyne, et al.
Pageof 4